Shanda Asset Management Holdings LTD Editas Medicine, Inc. Transaction History

Shanda Asset Management Holdings LTD

  • $1.77 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019
SELL
$22.49 - $26.81 $2.33 Million - $2.78 Million
-103,579 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$19.43 - $26.41 $971,500 - $1.32 Million
50,000 Added 93.32%
103,579 $2.53 Million
Q4 2018

Feb 14, 2019
BUY
$18.19 - $31.79 $974,602 - $1.7 Million
53,579 New
53,579 $1.22 Million

Others Institutions Holding EDIT

# of Institutions
247
Shares Held
57M
Call Options Held
410K
Put Options Held
394K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $173M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Shanda Asset Management Holdings LTD Portfolio

Follow Shanda Asset Management Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shanda Asset Management Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Shanda Asset Management Holdings LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email